Xiaohui Pu
Impact in
- Pharmaceutical Science top 2%
- Drug Solubulity and Delivery Systems
- Advanced Drug Delivery Systems
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
Papers in
- Biomaterials 22
- Nanoparticle-Based Drug Delivery 20
-
- RNA Interference and Gene Delivery 4
- Co-authors
- Lanlan Zong (17 shared papers)Zhonggui He (14 shared papers)Zhonggui He (7 shared papers)Yongjun Wang (4 shared papers)Jin Sun (8 shared papers)Mo Li (1 shared paper)Jihong Han (5 shared papers)Keke Yu (5 shared papers)
- Journals
- International Journal of Pharmaceutics (5 papers)Journal of Chromatography B (3 papers)Journal of Nanoparticle Research (2 papers)International Journal of Nanomedicine (2 papers)Current Cancer Drug Targets (2 papers)
- Partner nations
- ChinaUnited KingdomUnited States
In The Last Decade
Xiaohui Pu
45 papers receiving 941 citations
Peers
Comparison fields: 5 of 97
- Pharmaceutical Science 214
- Biomaterials 306
- Pharmacology 83
- Molecular Medicine 41
- Complementary and alternative medicine 43
Countries citing papers authored by Xiaohui Pu
This map shows the geographic impact of Xiaohui Pu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaohui Pu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaohui Pu more than expected).
Fields of papers citing papers by Xiaohui Pu
This network shows the impact of papers produced by Xiaohui Pu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaohui Pu. The network helps show where Xiaohui Pu may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaohui Pu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 97 | |
| 2 | 2009 | 72 | |
| 3 | 2011 | 64 | |
| 4 | 2008 | 64 | |
| 5 | 2019 | 42 | |
| 6 | 2021 | 41 | |
| 7 | 2011 | 37 | |
| 8 | 2024 | 34 | |
| 9 | 2017 | 33 | |
| 10 | 2024 | 31 | |
| 11 | 2019 | 29 | |
| 12 | 2018 | 27 | |
| 13 | 2020 | 26 | |
| 14 | 2014 | 25 | |
| 15 | 2021 | 25 | |
| 16 | 2021 | 25 | |
| 17 | 2010 | 22 | |
| 18 | 2018 | 21 | |
| 19 | 2021 | 21 | |
| 20 | 2013 | 20 |
About Xiaohui Pu
Xiaohui Pu is a scholar working on Biomaterials, Molecular Biology, Oncology, Biomedical Engineering and Pharmaceutical Science, having authored 47 papers that have together received 966 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (20 papers), Advanced Drug Delivery Systems (7 papers), Nanoplatforms for cancer theranostics (7 papers), Drug Solubulity and Delivery Systems (6 papers), Drug Transport and Resistance Mechanisms (6 papers), RNA Interference and Gene Delivery (4 papers), Cancer Treatment and Pharmacology (3 papers) and Dendrimers and Hyperbranched Polymers (3 papers). The work is most often cited by research in Pharmaceutical Science (214 citations), Biomaterials (306 citations), Pharmacology (83 citations), Molecular Medicine (41 citations) and Complementary and alternative medicine (43 citations). Xiaohui Pu has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Lanlan Zong, Zhonggui He, Zhonggui He, Yongjun Wang, Jin Sun, Mo Li, Jihong Han, Keke Yu, Qi Yuan and Peng Zhang. Their work appears in journals such as International Journal of Pharmaceutics, Journal of Chromatography B, Journal of Nanoparticle Research, International Journal of Nanomedicine and Current Cancer Drug Targets.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.